Nifty
Sensex
:
:
23398.10
74781.76
-79.70 (-0.34%)
-120.83 (-0.16%)

Pharmaceuticals & Drugs - Global

Rating :
42/99

BSE: 540701 | NSE: DCAL

167.25
11-Sep-2026
  • Open
  • High
  • Low
  • Previous Close
  •  167.49
  •  168.35
  •  163.57
  •  167.49
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  115563
  •  19188250.95
  •  321.95
  •  128.5

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,622.98
  • 162.31
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,407.17
  • N/A
  • 0.40

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 59.32%
  • 1.53%
  • 27.32%
  • FII
  • DII
  • Others
  • 6.86%
  • 1.41%
  • 3.56%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 50.27
  • 7.24
  • 3.97

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 45.57
  • 9.91
  • 5.77

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -46.55
  • -44.86

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.44
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.79
  • 0.97
  • 1.35

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.66
  • 11.08
  • 12.42

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
677.64
708.05
-4.29%
851.40
716.34
18.85%
719.80
682.34
5.49%
652.65
789.04
-17.29%
Expenses
617.56
567.37
8.85%
688.45
563.65
22.14%
606.69
542.21
11.89%
503.76
641.89
-21.52%
EBITDA
60.08
140.68
-57.29%
162.95
152.69
6.72%
113.11
140.13
-19.28%
148.89
147.15
1.18%
EBIDTM
8.87%
19.87%
19.14%
21.32%
15.71%
20.54%
22.81%
18.65%
Other Income
18.16
24.75
-26.63%
16.42
7.97
106.02%
6.66
5.63
18.29%
8.11
6.65
21.95%
Interest
37.09
42.76
-13.26%
43.30
42.12
2.80%
45.79
48.78
-6.13%
42.33
36.63
15.56%
Depreciation
90.68
81.35
11.47%
88.79
79.09
12.26%
84.42
71.97
17.30%
84.13
72.09
16.70%
PBT
-51.22
38.67
-
46.13
27.70
66.53%
-10.44
27.05
-
30.54
42.12
-27.49%
Tax
6.66
15.26
-56.36%
24.39
-15.39
-
2.53
22.42
-88.72%
-34.73
9.03
-
PAT
-57.88
23.41
-
21.74
43.09
-49.55%
-12.97
4.63
-
65.27
33.09
97.25%
PATM
-8.54%
3.31%
2.55%
6.02%
-1.80%
0.68%
10.00%
4.19%
EPS
-3.69
1.49
-
1.39
2.75
-49.45%
-0.83
0.30
-
4.16
2.11
97.16%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
2,901.49
2,711.50
2,615.77
2,412.92
2,140.69
1,912.03
2,043.60
2,058.60
1,694.79
1,713.69
Net Sales Growth
0.20%
3.66%
8.41%
12.72%
11.96%
-6.44%
-0.73%
21.47%
-1.10%
 
Cost Of Goods Sold
424.93
501.64
597.19
516.82
447.42
468.15
458.72
403.78
336.93
329.30
Gross Profit
2,476.56
2,209.86
2,018.58
1,896.10
1,693.27
1,443.88
1,584.88
1,654.82
1,357.86
1,384.39
GP Margin
85.35%
81.50%
77.17%
78.58%
79.10%
75.52%
77.55%
80.39%
80.12%
80.78%
Total Expenditure
2,416.46
2,271.77
2,351.85
2,080.72
1,815.04
1,637.82
1,546.04
1,506.70
1,256.77
1,260.34
Power & Fuel Cost
-
92.20
104.29
87.57
62.58
41.28
60.26
56.79
48.67
49.74
% Of Sales
-
3.40%
3.99%
3.63%
2.92%
2.16%
2.95%
2.76%
2.87%
2.90%
Employee Cost
-
1,293.57
1,208.16
1,029.86
981.49
872.91
762.27
714.64
625.40
596.02
% Of Sales
-
47.71%
46.19%
42.68%
45.85%
45.65%
37.30%
34.71%
36.90%
34.78%
Manufacturing Exp.
-
166.79
209.66
171.92
144.91
118.31
118.03
114.69
83.69
98.02
% Of Sales
-
6.15%
8.02%
7.12%
6.77%
6.19%
5.78%
5.57%
4.94%
5.72%
General & Admin Exp.
-
157.05
159.87
142.69
104.71
82.76
90.42
157.80
112.15
81.58
% Of Sales
-
5.79%
6.11%
5.91%
4.89%
4.33%
4.42%
7.67%
6.62%
4.76%
Selling & Distn. Exp.
-
32.72
24.80
35.47
29.44
21.94
23.40
20.90
18.56
58.54
% Of Sales
-
1.21%
0.95%
1.47%
1.38%
1.15%
1.15%
1.02%
1.10%
3.42%
Miscellaneous Exp.
-
27.80
47.88
96.39
44.49
32.47
32.94
38.10
31.37
47.14
% Of Sales
-
1.03%
1.83%
3.99%
2.08%
1.70%
1.61%
1.85%
1.85%
2.75%
EBITDA
485.03
439.73
263.92
332.20
325.65
274.21
497.56
551.90
438.02
453.35
EBITDA Margin
16.72%
16.22%
10.09%
13.77%
15.21%
14.34%
24.35%
26.81%
25.85%
26.45%
Other Income
49.35
50.89
50.79
27.77
49.14
38.59
44.46
53.82
53.02
26.13
Interest
168.51
159.46
119.97
85.69
56.81
47.61
61.95
56.55
48.83
49.01
Depreciation
348.02
293.74
310.86
280.72
307.59
307.94
282.87
240.38
211.42
213.50
PBT
15.01
37.42
-116.12
-6.44
10.39
-42.75
197.20
308.79
230.79
216.97
Tax
-1.15
16.07
31.19
-24.79
-22.26
100.10
38.69
98.46
76.22
70.65
Tax Rate
-7.66%
83.22%
-25.51%
45.41%
523.76%
-153.93%
19.62%
31.89%
33.03%
32.56%
PAT
16.16
3.24
-153.45
-29.80
18.01
-165.13
158.51
210.33
154.57
145.43
PAT before Minority Interest
16.16
3.24
-153.45
-29.80
18.01
-165.13
158.51
210.33
154.57
145.43
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
0.56%
0.12%
-5.87%
-1.24%
0.84%
-8.64%
7.76%
10.22%
9.12%
8.49%
PAT Growth
-84.49%
-
-
-
-
-
-24.64%
36.07%
6.28%
 
EPS
1.03
0.21
-9.79
-1.90
1.15
-10.53
10.11
13.41
9.86
9.27

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
5,831.52
5,627.50
5,809.67
5,548.94
5,698.82
5,715.06
5,379.09
5,107.33
4,813.98
Share Capital
31.36
31.36
31.36
31.36
31.36
31.38
32.28
32.28
0.00
Total Reserves
5,800.16
5,596.14
5,778.31
5,517.58
5,667.46
5,683.68
5,346.81
5,075.05
3.98
Non-Current Liabilities
2,230.03
1,388.40
1,831.43
1,665.47
1,366.74
909.40
743.13
883.95
766.66
Secured Loans
1,129.02
245.61
1,046.65
761.96
503.94
222.41
310.55
386.16
241.45
Unsecured Loans
20.17
0.00
0.00
0.00
0.00
18.89
51.87
138.81
218.67
Long Term Provisions
352.43
379.04
233.16
277.09
310.99
294.08
248.31
234.34
221.40
Current Liabilities
1,924.79
2,554.72
1,798.39
1,419.79
1,290.30
1,568.95
1,198.31
1,177.72
993.66
Trade Payables
230.68
244.12
219.73
193.37
169.23
283.52
194.57
185.92
85.64
Other Current Liabilities
993.23
639.53
841.64
702.41
558.68
578.83
430.36
515.88
457.19
Short Term Borrowings
655.35
1,620.23
680.76
492.64
542.47
688.23
520.09
393.31
384.95
Short Term Provisions
45.53
50.84
56.26
31.37
19.92
18.37
53.29
82.61
65.88
Total Liabilities
9,986.34
9,570.62
9,439.49
8,634.20
8,355.86
8,193.41
7,320.53
7,169.00
6,574.30
Net Block
7,050.72
6,720.08
6,183.17
5,768.14
5,693.34
5,672.85
5,092.37
5,060.70
4,847.25
Gross Block
10,545.34
10,308.48
9,457.72
8,633.43
8,155.29
7,890.70
6,896.88
6,621.19
6,187.07
Accumulated Depreciation
3,494.62
3,588.40
3,274.55
2,865.29
2,461.95
2,217.85
1,804.51
1,560.49
1,339.82
Non Current Assets
7,785.92
7,642.43
7,521.13
6,795.48
6,651.72
6,414.44
5,766.95
5,622.85
5,241.25
Capital Work in Progress
466.84
645.74
1,043.25
779.51
485.78
234.17
175.25
150.71
132.88
Non Current Investment
71.96
78.85
72.10
31.83
55.78
84.02
147.41
101.43
39.62
Long Term Loans & Adv.
190.47
192.78
217.24
210.78
411.53
412.88
345.40
299.33
200.63
Other Non Current Assets
1.79
0.66
0.81
0.66
0.35
5.45
1.32
5.51
16.24
Current Assets
2,200.42
1,928.19
1,918.36
1,838.72
1,704.14
1,778.97
1,553.58
1,546.15
1,333.05
Current Investments
25.43
23.29
176.97
292.53
116.44
106.61
19.72
94.35
0.00
Inventories
900.24
882.89
803.80
645.12
515.65
580.87
548.62
484.56
426.58
Sundry Debtors
665.14
484.47
589.91
473.42
420.71
577.43
445.30
444.40
285.55
Cash & Bank
507.03
413.35
189.17
172.09
307.74
160.98
95.67
69.06
87.39
Other Current Assets
102.58
45.15
37.54
66.08
343.60
353.08
444.27
453.78
533.53
Short Term Loans & Adv.
80.17
79.04
120.97
189.48
197.57
277.10
309.17
373.27
361.20
Net Current Assets
275.63
-626.53
119.97
418.93
413.84
210.02
355.27
368.43
339.39
Total Assets
9,986.34
9,570.62
9,439.49
8,634.20
8,355.86
8,193.41
7,320.53
7,169.00
6,574.30

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
375.23
379.43
265.95
354.85
512.66
585.14
282.03
226.44
302.65
PBT
19.31
-122.26
-54.59
-4.25
-65.03
197.20
308.79
230.79
216.08
Adjustment
466.83
376.83
392.46
325.36
312.54
330.11
277.24
235.49
231.80
Changes in Working Capital
-80.59
143.83
-37.73
90.08
316.35
132.23
-174.47
-206.26
-29.43
Cash after chg. in Working capital
405.55
398.40
300.14
411.19
563.86
659.54
411.56
260.02
418.45
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-30.32
-18.97
-34.19
-56.34
-51.20
-74.40
-129.53
-33.58
-115.80
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-192.21
-229.52
-494.08
-618.53
-380.02
-441.74
-169.02
-297.16
-142.41
Net Fixed Assets
-16.28
-47.06
-143.00
28.96
-52.16
-76.56
-15.68
-66.76
Net Investments
7.27
64.69
119.43
-150.57
18.40
6.58
30.41
-175.91
Others
-183.20
-247.15
-470.51
-496.92
-346.26
-371.76
-183.75
-54.49
Cash from Financing Activity
-102.09
-22.15
249.68
130.37
-11.04
-97.78
-102.20
77.63
-137.08
Net Cash Inflow / Outflow
80.93
127.76
21.55
-133.31
121.60
45.62
10.81
6.91
23.16
Opening Cash & Equivalents
264.09
131.79
110.24
243.55
121.94
76.32
65.52
58.61
0.00
Closing Cash & Equivalent
341.07
264.09
131.79
110.24
243.54
121.94
76.33
65.52
58.61

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
371.91
358.90
370.51
353.89
363.45
364.25
333.28
316.44
0.00
ROA
0.03%
-1.61%
-0.33%
0.21%
-2.00%
2.04%
2.90%
2.25%
2.23%
ROE
0.06%
-2.68%
-0.52%
0.32%
-2.89%
2.86%
4.01%
6.05%
3676.38%
ROCE
2.31%
-0.03%
0.43%
0.76%
-0.26%
3.93%
5.79%
4.67%
4.61%
Fixed Asset Turnover
0.26
0.26
0.27
0.26
0.24
0.28
0.30
0.26
0.28
Receivable days
77.38
74.96
80.42
76.23
95.27
91.33
78.87
78.60
60.82
Inventory Days
120.02
117.68
109.59
98.96
104.66
100.87
91.59
98.11
90.86
Payable days
172.74
141.75
145.87
147.90
176.50
49.83
43.67
37.47
22.81
Cash Conversion Cycle
24.66
50.89
44.14
27.28
23.44
142.37
126.80
139.24
128.86
Total Debt/Equity
0.36
0.35
0.31
0.26
0.20
0.18
0.19
0.21
238.62
Interest Cover
1.12
-0.02
0.36
0.93
-0.37
4.18
6.46
5.73
5.43

News Update:


  • Dishman Carbogen Amcis raises Rs 75 crore through NCDs
    17th Aug 2026, 16:42 PM

    The Management Committee of Board of Directors has at its meeting held on August 17, 2026 approved allotment of the same

    Read More
  • Dishman Carbogen Amcis gets nod to raise Rs 75 crore via NCDs
    12th Aug 2026, 12:39 PM

    The Board of Directors of the Company has at its meeting held on August 12, 2026 approved the same

    Read More
  • Dishman Carbogen Amcis raises Rs 18 crore through NCDs
    10th Jun 2026, 09:58 AM

    The final maturity date of the NCDs is December 9, 2027

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.